Welcome to our dedicated page for Yokogawa Electri news (Ticker: YOKEY), a resource for investors and traders seeking the latest updates and insights on Yokogawa Electri stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Yokogawa Electri's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Yokogawa Electri's position in the market.
Yokogawa Electric Corporation has acquired PXiSE Energy Solutions LLC, a San Diego-based provider of software that enhances renewable energy management and grid resilience. Founded in 2016, PXiSE developed Active Control Technology, which optimizes energy distribution and integrates distributed energy resources. The acquisition will bolster Yokogawa's capabilities in monitoring and controlling power generation, enabling clients to meet clean energy goals. This strategic move positions Yokogawa to support a more diversified energy supply chain and enhance operational efficiency in renewable energy.
Yokogawa Electric Corporation has developed the Single Cellome™ System SS2000, an advanced single-cell analysis solution that automates the collection of specific cells and intracellular components. This innovative system employs high-resolution imaging from confocal microscopy to enhance the efficiency of drug discovery research. The SS2000 will be launched in February 2022 in Japan, the US, and China, with subsequent releases in other markets. This development aims to improve understanding of cellular characteristics and enhance precision medicine efforts.
Yokogawa Electric Corporation has acquired Insilico Biotechnology AG, a Stuttgart-based firm specializing in bioprocess software. This acquisition aligns with Yokogawa’s sustainability goals to foster the bioeconomy, aiming to enhance biopharmaceutical development and manufacturing. Insilico’s digital twin technology promises to optimize the production process by enabling real-time data analysis, improving quality control, and accelerating development timelines. Insilico's expertise will help Yokogawa expand its reach in the biopharmaceutical sector.